Cargando…
Cell Therapy of Stroke: Do the Intra-Arterially Transplanted Mesenchymal Stem Cells Cross the Blood–Brain Barrier?
Animal model studies and first clinical trials have demonstrated the safety and efficacy of the mesenchymal stem cells’ (MSCs) transplantation in stroke. Intra-arterial (IA) administration looks especially promising, since it provides targeted cell delivery to the ischemic brain, is highly effective...
Autores principales: | Yarygin, Konstantin N., Namestnikova, Daria D., Sukhinich, Kirill K., Gubskiy, Ilya L., Majouga, Alexander G., Kholodenko, Irina V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616541/ https://www.ncbi.nlm.nih.gov/pubmed/34831220 http://dx.doi.org/10.3390/cells10112997 |
Ejemplares similares
-
Comparative study of the efficacy of intra-arterial and intravenous transplantation of human induced pluripotent stem cells-derived neural progenitor cells in experimental stroke
por: Cherkashova, Elvira, et al.
Publicado: (2023) -
Methodological aspects of MRI of transplanted superparamagnetic iron oxide-labeled mesenchymal stem cells in live rat brain
por: Namestnikova, Daria, et al.
Publicado: (2017) -
Combined Cell Therapy in the Treatment of Neurological Disorders
por: Namestnikova, Daria D., et al.
Publicado: (2020) -
The Impact of Cerebral Perfusion on Mesenchymal Stem Cells Distribution after Intra-Arterial Transplantation: A Quantitative MR Study
por: Gubskiy, Ilya L., et al.
Publicado: (2022) -
Dynamic MRI of the Mesenchymal Stem Cells Distribution during Intravenous Transplantation in a Rat Model of Ischemic Stroke
por: Cherkashova, Elvira A., et al.
Publicado: (2023)